4.7 Article

The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children

期刊

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 71, 期 4, 页码 1106-1117

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkv418

关键词

-

资金

  1. European Commission Directorate General for Health and Consumers (DG SANCO) through the Executive Agency for Health and Consumers [2009 11 01]
  2. Paediatric European Network for Treatment of AIDS (PENTA)
  3. National Institute for Health Research [CL-2014-13-001] Funding Source: researchfish

向作者/读者索取更多资源

Previously, web-based tools for cross-sectional antimicrobial point prevalence surveys (PPSs) have been used in adults to develop indicators of quality improvement. We aimed to determine the feasibility of developing similar quality indicators of improved antimicrobial prescribing focusing specifically on hospitalized neonates and children worldwide. A standardized antimicrobial PPS method was employed. Included were all inpatient children and neonates receiving an antimicrobial at 8:00 am on the day of the PPS. Denominators included the total number of inpatients. A web-based application was used for data entry, validation and reporting. We analysed 2012 data from 226 hospitals (H) in 41 countries (C) from Europe (174H; 24C), Africa (6H; 4C), Asia (25H; 8C), Australia (6H), Latin America (11H; 3C) and North America (4H). Of 17aEuroS693 admissions, 6499 (36.7%) inpatients received at least one antimicrobial, but this varied considerably between wards and regions. Potential indicators included very high broad-spectrum antibiotic prescribing in children of mainly ceftriaxone (ranked first in Eastern Europe, 31.3%; Asia, 13.0%; Southern Europe, 9.8%), cefepime (ranked third in North America, 7.8%) and meropenem (ranked first in Latin America, 13.1%). The survey identified worryingly high use of critically important antibiotics for hospital-acquired infections in neonates (34.9%; range from 14.2% in Africa to 68.0% in Latin America) compared with children (28.3%; range from 14.5% in Africa to 48.9% in Latin America). Parenteral administration was very common among children in Asia (88%), Latin America (81%) and Europe (67%). Documentation of the reasons for antibiotic prescribing was lowest in Latin America (52%). Prolonged surgical prophylaxis rates ranged from 78% (Europe) to 84% (Latin America). Simple web-based PPS tools provide a feasible method to identify areas for improvement of antibiotic use, to set benchmarks and to monitor future interventions in hospitalized neonates and children. To our knowledge, this study has derived the first global quality indicators for antibiotic use in hospitalized neonates and children.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Pediatrics

Off-label prescription of BNT162b2 mRNA COVID-19 vaccine to <5-year-old children in the European Union

Rafael Dal-Re, Cristina Calvo, Olaf Neth

ACTA PAEDIATRICA (2023)

Article Immunology

Novel Human Parechovirus 3 Diversity, Recombination, and Clinical Impact Across 7 Years: An Australian Story

Seweryn Bialasiewicz, Meryta May, Sarah Tozer, Rebecca Day, Anne Bernard, Julian Zaugg, Kyana Gartrell, Soren Alexandersen, Anthony Chamings, Claire Y. T. Wang, Julia Clark, Keith Grimwood, Claire Heney, Luregn Schlapbach, Robert S. Ware, David Speers, Ross M. Andrews, Stephen Lambert

Summary: A study found that the recombinant strain of human parechovirus 3 (HPeV3-AR) was the dominant strain in the outbreaks of sepsis-like illnesses in infants in Australia. However, this strain was not associated with increased disease severity.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Virology

Early Treatments of Fragile Children with COVID-19-Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study

Chiara Minotti, Daniele Mengato, Marica De Pieri, Sabrina Trivellato, Andrea Francavilla, Costanza Di Chiara, Cecilia Liberati, Raffaele Mattera, Alessandra Biffi, Carlo Giaquinto, Francesca Venturini, Daniele Dona

Summary: This retrospective observational study investigated the safety of monoclonal antibodies and antivirals for the prevention of severe COVID-19 in fragile pediatric patients with mild-to-moderate symptoms. The results showed that antivirals were as effective and safe as monoclonal antibodies for early treatment of COVID-19 in children. This suggests that antivirals are a valuable choice for treating COVID-19 in fragile children, even when administered off-label.

VIRUSES-BASEL (2023)

Article Pediatrics

Blood analysis for screening of electrolyte and kidney function alterations in patients with febrile urinary tract infection

Isabel Gonzalez-Bertolin, Guillermo Barbas Bernardos, Leire Garcia Suarez, Irene Martin Espin, Cristina Barcia Aguilar, Rosario Lopez Lopez, Cristina Calvo

Summary: This study retrospectively observed 590 children diagnosed with febrile urinary tract infections (fUTIs) and found that electrolyte and renal function disturbances were rare in this population and often asymptomatic. Therefore, systematic blood analysis may not be necessary in the absence of risk factors.

ACTA PAEDIATRICA (2023)

Article Gastroenterology & Hepatology

Inadequate Hospital Practices to Prevent Mother-to-Child Transmission of Hepatitis B Virus Infection: A European Survey

Michele Pinon, Laura Giugliano, Francesca Rocchi, Mara Cananzi, Cinzia Auriti, Barbara Wade, Pier Luigi Calvo, Carlo Giaquinto, Giuseppe Indolfi

Summary: A survey revealed significant heterogeneity in hospital policies and practices for the prevention of vertical transmission of hepatitis B virus infection in Europe. The implementation of a multidisciplinary clinical pathway is necessary to establish a stronger connection between the prenatal, perinatal, and postnatal phases.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2023)

Article Obstetrics & Gynecology

Inequity of antenatal influenza and pertussis vaccine coverage in Australia: the Links2HealthierBubs record linkage cohort study, 2012-2017

Lisa McHugh, Annette K. Regan, Mohinder Sarna, Hannah C. Moore, Paul Van Buynder, Gavin Pereira, Christopher C. Blyth, Karin Lust, Ross M. Andrews, Kristy Crooks, Peter Massey, Michael J. Binks

Summary: Compared to other Australian women, First Nations women are less likely to receive recommended antenatal vaccines, while women from culturally and linguistically diverse backgrounds are more likely to receive them. Women living in remote areas are less likely to be vaccinated, while women living in areas of advantage are more likely to be vaccinated. Addressing these disparities should be a core priority for the Australian healthcare system and vaccine providers.

BMC PREGNANCY AND CHILDBIRTH (2023)

Article Pediatrics

Vaccination practices in pediatric transplantation: A survey among member centers of the European reference network TransplantChild

Daniele Dona, Luz Yadira Bravo-Gallego, Esteban Frauca Remacha, Mara Cananzi, Andrea Gastaldi, Juan Torres Canizalez, Xavier Stephenne, Florence Lacaille, Caroline Lindemans, Elisabetta Calore, Nathalie Galea, Elisa Benetti, Edith Nachbaur, Ana Rita Sandes, Ana Teixeira, Sandra Ferreira, Maja Klaudel-Dreszler, Oanez Ackermann, Olivia Boyer, Laura Espinosa, Luis Garcia Guereta, Marco Sciveres, Bjoern Fischler, Nicolaus Schwerk, Mette Neland, Emanuele Nicastro, Luca Dello Strologo, Jacek Toporski, Inga Vainumae, Jelena Rascon, Vaidotas Urbonas, Teresa del Rosal, Eduardo Lopez-Granados, Giorgio Perilongo, Alastair Baker, Paloma Jara Vega

Summary: This study evaluates the attitudes and practices of pediatric transplant centers towards active immunization and highlights inconsistent immunization coverage among European pediatric transplant recipients. The findings emphasize the need for shared evidence-based immunization protocols and further research.

PEDIATRIC TRANSPLANTATION (2023)

Article Medicine, Research & Experimental

Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccines among pregnant women (the EPIC study): study protocol

Prabha H. H. Andraweera, Bing Wang, Margie Danchin, Christopher Blyth, Ivo Vlaev, Jason Ong, Jodie Dodd, Jennifer Couper, Thomas R. R. Sullivan, Jonathan Karnon, Nicola Spurrier, Michael Cusack, Dylan Mordaunt, Dimi Simatos, Gus Dekker, Samantha Carlson, Jane Tuckerman, Nicholas Wood, Lisa Whop, Helen S. S. Marshall

Summary: This study aims to assess the effectiveness of a multi-component nudge intervention to improve influenza and COVID-19 vaccine uptake among pregnant women. The intervention includes SMS text message reminders and educational videos to increase vaccination rates. The results of this study will provide guidance for future vaccination efforts among pregnant women.

TRIALS (2023)

Article Endocrinology & Metabolism

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby, Natalie Staplin, Leon Peto, Jonathan R. Emberson, Mark Campbell, Guilherme Pessoa-Amorim, Buddha Basnyat, Louise Thwaites, Rogier van Doorn, Raph L. Hamers, Jeremy Nel, John Amuasi, Manisha Rawal, Dipansu Ghosh, Jonathan Douse, Fergus Hamilton, Anthony Kerry, Pinky Thu-Ta, John Widdrington, Christopher A. Green, Purav Desai, Richard Stewart, Nguyen Thanh Phong, J. Kenneth Baillie, Maya Buch, Saul N. Faust, Thomas Jaki, Edmund Juszczak, Katie Jeffery, Marian Knight, Wei Shen Lim, Alan Montgomery, Aparna Mukherjee, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J. Landray

Summary: Empagliflozin is not associated with reduced mortality, hospital stay, or progression to invasive mechanical ventilation or death in hospitalized adults with COVID-19.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Article Immunology

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

Bruno Salaun, Jonathan De Smedt, Charlotte Vernhes, Annick Moureau, Deniz Oner, Arangassery Rosemary Bastian, Michel Janssens, Sunita Balla-Jhagjhoorsingh, Jeroen Aerssens, Christophe Lambert, Samuel Coenen, Christopher C. Butler, Simon B. Drysdale, Joanne G. Wildenbeest, Andrew J. Pollard, Peter J. M. Openshaw, Louis Bont, RESCEU Investigators

Summary: Cellular immunity plays a primary role in preventing symptomatic RSV infections in older adults, according to a study. T-cell data were found to be more predictive of RSV infection than functional antibody data.

FRONTIERS IN IMMUNOLOGY (2023)

Article Infectious Diseases

Neonatal Bloodstream Infection with Ceftazidime-Avibactam-Resistant bla(KPC-2)-Producing Klebsiella pneumoniae Carrying bla(VEB-25)

Charalampos Zarras, Elias Iosifidis, Maria Simitsopoulou, Styliani Pappa, Angeliki Kontou, Emmanuel Roilides, Anna Papa

Summary: This article reports a case of neonatal sepsis caused by CAZ/AVI-resistant bla(KPC-2)-harboring Klebsiella pneumoniae carrying bla(VEB-25), and describes the use of a customized active surveillance program and enhanced infection control measures. The emergence of bla(VEB-25) signals horizontal plasmid transfer in hospital facilities and highlights the importance of monitoring for novel resistance mechanisms. Molecular diagnostics can guide appropriate antimicrobial therapy and the early implementation of infection control measures against antimicrobial resistance.

ANTIBIOTICS-BASEL (2023)

Review Medicine, General & Internal

Continuous Glucose Monitoring in Transient Neonatal Diabetes Mellitus-2 Case Reports and Literature Review

Tatiana Chisnoiu, Adriana Luminita Balasa, Larisia Mihai, Ancuta Lupu, Corina Elena Frecus, Irina Ion, Antonio Andrusca, Alexandru Cosmin Pantazi, Maria Nicolae, Vasile Valeriu Lupu, Constantin Ionescu, Cristina Maria Mihai, Simona Claudia Cambrea

Summary: Neonatal diabetes mellitus, a rare genetic disease, affects 1 in 90,000 live births. Onset of the disease is often before 6 months old, with rare cases between 6 months and 1 year. It is characterized by low or absent insulin levels, requiring temporary or permanent insulin therapy. This research discusses two cases of preterm girls with neonatal diabetes mellitus, reviewing mutations, patient care, and clinical outcomes.

DIAGNOSTICS (2023)

Article Infectious Diseases

Sotrovimab Use in Young Pediatric Patients at High Risk of Progression to Severe COVID-19 Disease

Elizabeth White, Amy Legg, Alexandra Bogart, Nicolette Graham, Faten Jebreen, Julia E. Clark

Summary: This retrospective analysis examines the use of sotrovimab in 32 at-risk children with COVID-19, providing dosing recommendations and demonstrating its feasibility in the pediatric population under 12 years old and under 40 kg.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2023)

Review Nutrition & Dietetics

Nutritional Care in Children with Cystic Fibrosis

Elena Mariotti Zani, Roberto Grandinetti, Daniela Cunico, Lisa Torelli, Valentina Fainardi, Giovanna Pisi, Susanna Esposito

Summary: Patients with cystic fibrosis (CF) are prone to malnutrition and growth failure due to malabsorption caused by chloride transport derangement. Optimal nutritional care and support are crucial for improving clinical outcomes and life expectancy. This report analyzes the nutrition support in CF patients of different ages, focusing on the relationship with growth, nutritional status, disease outcomes, and the use of CFTR modulators. Early nutrition support in CF should aim at achieving optimal nutritional status to support growth and development in children and maintain it in adulthood. This involves a high calorie, high-fat diet, pancreatic enzyme replacement therapy, and adequate supplementation of fat-soluble vitamins. Supplemental enteral feeding may be needed when oral intake is insufficient. CFTR modulators have positive effects on nutritional status, including weight gain, BMI improvement, pulmonary function, and reduction of exacerbations. Challenges remain in developing new drugs to transform CF into a treatable chronic disease with specialized multidisciplinary care.

NUTRIENTS (2023)

Review Medicine, General & Internal

The First-Line Approach in Children with Obstructive Sleep Apnea Syndrome (OSA)

Nicole Mussi, Roberta Forestiero, Giulia Zambelli, Letizia Rossi, Maria Rosaria Caramia, Valentina Fainardi, Susanna Esposito

Summary: Obstructive sleep apnea syndrome (OSA) is the main manifestation of sleep-disordered breathing in children. Adenoid and/or tonsil hypertrophy are the most common causes of upper airway lumen reduction in children aged 2 years or older. Both surgical and non-surgical options are effective treatments for OSA in children.

JOURNAL OF CLINICAL MEDICINE (2023)

暂无数据